Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CJ-30060 in Hypertensive Patients With Hyperlipidemia
NCT03536598Phase 3Completed
- Sponsor
- HK inno.N Corporation
- Start
- Oct 2016
- Primary completion
- Sep 2017
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of amlodipine, valsartan, rosuvastatin in hypertension (HTN), hyperlipidemia, sponsored by HK inno.N Corporation. Started Oct 2016; status: completed.
02
Drugs
amlodipinevalsartanrosuvastatin
03
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT03536598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03536598.